StockData
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) stock

XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 0/30
$1.06+0.02 (+1.92%)

Close on Nov 17, 2026Market cap $116.17KP/E –Yield –

XORTX Therapeutics r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2021 it was C$853.12K, up 207.5% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2021Dec 31, 2021C$853.12K+207.5%
FY2020Dec 31, 2020C$277.46K+595.4%
FY2019Dec 31, 2019C$39.90K–

More XORTX Therapeutics figures

See a number that looks wrong?